Dirty Equipment Hold Time Study Report: Injection Ampoule Section
Contents
In short: A dirty equipment hold time (DEHT) study proves the longest period that used equipment can wait before cleaning and still be cleaned to the same standard. This article explains how to plan and report one for an injection ampoule section, with an example report format. All numbers in the example are illustrative and must be replaced with your own validated data.
What is a dirty equipment hold time?
The dirty equipment hold time is the maximum time between the end of manufacture (or use) and the start of cleaning. During this wait, product residue can dry and harden, and micro-organisms can multiply, so cleaning becomes harder. The related clean equipment hold time is the maximum time cleaned equipment may be stored before it is used again.
Both are expected by the regulators. EU GMP Annex 15 says the time between manufacture and cleaning, and between cleaning and use, should be taken into account to define dirty and clean hold times for the cleaning process (Annex 15, clause 10.8). The WHO guideline on validation lists, as content of a cleaning validation protocol, the maximum period equipment may be left dirty and the time that should elapse after cleaning and before use (WHO TRS 1019, Annex 3, Appendix 3).
In an injection ampoule section the risk is higher than in oral dosage areas. The product is injected, so residue, bioburden and endotoxin carry-over matter directly to patient safety.
Equipment and products to include
Choose equipment that is representative of routine production. For an ampoule section this normally means:
- the manufacturing vessel, transfer lines and filter housings;
- the filling machine product path (filling needles, pump, manifold);
- the ampoule-washing and sterilising equipment, where product contact occurs.
Group similar equipment and justify the worst case. The worst-case product is usually the one that is hardest to clean, least soluble or most potent, or that supports microbial growth most. Record each item with its type, location and unique ID.
Protocol design
Dirty hold time conditions
- Complete a normal batch (or a worst-case simulation) and leave the equipment dirty without cleaning.
- Hold the equipment in the normal storage condition of the area for the test periods, for example 0, 12, 24 and 48 hours (example in-house criterion; choose periods that cover your realistic delays, including weekends).
- At each period, clean the equipment using the approved cleaning SOP exactly as in routine practice.
- Sample and test after cleaning.
Clean hold time conditions
Clean and dry the equipment, protect it as in routine practice (covered, wrapped or stored in a classified area) and sample after defined periods. If sterilised equipment is used, the sterile hold time is studied separately.
Sampling
Select sampling points by risk: hard-to-clean locations, dead legs, valves, gaskets, filling needles and the lowest points where liquid collects. Use swab sampling for surfaces and rinse sampling for lines and closed parts. Use the recovery factors from the validated sampling method.
Tests
| Test | Purpose |
|---|---|
| Visual inspection | No visible residue (necessary, but not sufficient on its own) |
| Active residue by validated method (e.g. HPLC, TOC) | Carry-over of the product |
| Cleaning agent residue (if used) | Detergent removal |
| Bioburden (TAMC / TYMC) | Microbial growth during hold |
| Bacterial endotoxin (LAL) | Endotoxin from microbial growth |
| Conductivity / pH of final rinse | Indicative cleanliness |
Particulate contamination is mainly controlled by the cleaning procedure, filtration and the clean-area environment. It can be added as a visual or particle check on final rinse water where the process justifies it.
Acceptance criteria
Set the criteria before the study, with a scientific rationale. Residue limits come from your approved cleaning validation (for example a health-based exposure limit calculation). Bioburden and endotoxin limits must be consistent with the cleaning validation and the intended bioburden control of the product. Example in-house criteria used in the report below: no visible residue; residue below the approved limit; final rinse bioburden within the approved alert and action levels; endotoxin within the approved limit.
Critical parameters and risks
- Equipment design and condition: crevices, worn gaskets and dead legs hold residue and organisms.
- Cleaning procedure: the study is valid only when the routine cleaning SOP is followed unchanged.
- Ambient conditions: temperature, humidity and area classification influence drying and microbial growth.
- Product characteristics: solubility, viscosity and the ability to support microbial growth.
- Microbial contamination and endotoxin: growth during a long dirty hold can create endotoxin that is not removed by later sterilisation.
Example report format
The table below shows how results can be presented. The data are illustrative only and are not real study results.
| Item | Hold period | Visual | Residue vs limit | Bioburden (CFU) | Endotoxin | Result |
|---|---|---|---|---|---|---|
| Filling machine product path | 0 h | Clean | Below limit | Within limit | Within limit | Pass |
| Filling machine product path | 24 h | Clean | Below limit | Within limit | Within limit | Pass |
| Filling machine product path | 48 h | Clean | Below limit | Within limit | Within limit | Pass |
Report contents
- Objective and scope
- Reference documents (cleaning validation protocol, cleaning SOP, analytical methods)
- Equipment list with IDs and worst-case rationale
- Study design, sampling plan and acceptance criteria
- Results for each hold period, with raw data references
- Deviations and investigations
- Conclusion: the approved dirty hold time (for example “up to 24 hours”) and clean hold time
- Recommendations, such as the procedure when the hold time is exceeded (re-clean, extra sampling, or deviation)
- Approval signatures
If any result fails, do not simply repeat sampling until it passes. Investigate the cause, correct the cleaning process or shorten the hold time, and repeat the study. Include the approved hold time in the batch record or cleaning SOP and monitor it routinely.
Records
Keep protocols, raw data, chromatograms and reports as GMP records for at least 1 year after the expiry date of the respective product batch (EU GMP Part I, Chapter 4, clause 4.11; 21 CFR 211.180(a)), longer if local law or the marketing authorisation requires.
Frequently asked questions
Is a hold time study a one-time activity? No. Repeat it after changes to the product, equipment, cleaning procedure or hold period, and review it as part of the periodic cleaning validation review.
Can the dirty hold time be the same for all products? Only if the worst-case product is studied and the rationale is documented. Otherwise define the time per product group.
What if the equipment is left dirty longer than the approved time? Raise a deviation, assess the risk, and re-clean with extra verification before use.
Is visual cleanliness enough? No. Annex 15 states that visual inspection cannot be the only acceptance criterion; combine it with analytical and microbiological results.
See also
- Cleaning validation protocol format
- Principles of cleaning validation
- SOP on cleaning validation
- Production of sterile pharmaceutical products
References
- European Commission, EudraLex Volume 4, Annex 15: Qualification and Validation, clauses 10.1-10.8 (in operation since 1 October 2015).
- WHO Technical Report Series No. 1019 (2019), Annex 3: Good manufacturing practices: guidelines on validation, Appendix 3: Cleaning validation.
- EudraLex Volume 4, Part I, Chapter 4: Documentation, clause 4.11.
- US FDA, 21 CFR 211.180(a): General requirements for records and reports.
Related articles
GMP Self-Inspection Checklist (Free Printable)
Free printable GMP self-inspection checklist for pharma plants: 8 areas, 60+ yes/no checks mapped to EU GMP chapters and 21 CFR 211 sections.
Critical Quality Attributes in Tablet Compression
Which critical quality attributes (CQAs) matter at the tablet compression stage, how they link to press parameters, and how to monitor weight, hardness and friability.
Data Processing in QC Lab Equipment: GMP Requirements
What GMP expects when QC lab computers and instruments collect, process, store and report test data: validation, access control, audit trail, change control and backup.
Operational Qualification (OQ) Protocol and Report Format
An example operational qualification (OQ) protocol and report format for pharma equipment and systems, based on EU GMP Annex 15, with test charts and a deviation record.